Tue, Jan
90 New Articles

Kinstellar Advises Neuraxpharm on European Expansion

Kinstellar Advises Neuraxpharm on European Expansion

Deals and Cases
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Kinstellar has advised Neuraxpharm Group on the acquisition of Farmax from SVUS Pharma in the Czech Republic, Slovakia, and Hungary. BBH reportedly advised SVUS Pharma on the sale.

The terms of the transaction were not disclosed.

Farmax, located in Hradec Kralove, Czech Republic, is a central nervous system (CNS)specialty pharmaceutical company and a distributor of both branded and non-branded generics pharmaceuticals for CNS disorder in the Czech Republic, Slovakia, and Hungary. Farmax will be renamed Neuraxpharm Bohemia and will commercialize its products under the Neuraxpharm brand. 

Neuraxpharm Group is a European specialty pharmaceutical company focused on the treatment of CNS disorders, and it is a part of the APAX portfolio group of companies.

Kinstellar’s team was led by Partner Lukas Sevcik and included Senior Associates Tereza Naucova and Adam Nemec, Associate Martin Holub, and Junior Associates Michal Matous, Tereza Maskova, and Vaclav Kment.

Editor’s Note: After this article was published BBH confirmed its involvement in the deal. The team was led by Partner Tomas Sedlacek, assisted by Senior Associate Alice Nytrova and Associate Ondrej Stanek.

Czech Republic Knowledge Partner

HAVEL & PARTNERS, attorneys-at-law, with offices in Prague, Brno, Bratislava, Pilsen, Olomouc, and Ostrava, has a team of 220 lawyers, tax advisors and 500 employees in total, is the largest independent law firm in Central Europe.

Our clients include large international companies, leading Czech and Slovak firms, including strategic state-owned companies and public sector authorities, as well as medium-size businesses, individual entrepreneurs, and investors. We advise approximately 100 of the Fortune 500 companies, and almost 50 of the Czech Top 100 companies. HAVEL & PARTNERS currently provides its services to a total of 2,000 clients. We have the most comprehensive international support available to both Czech and Slovak law firms. We provide legal and tax advice in 12 world languages in more than 90 countries around the globe. Up to 70 % of the transactions we deal with involve an international aspect.

HAVEL & PARTNERS was named the best law firm operating in the Czech Republic by the prestigious British rating agencies Chambers and Partners (2020) and Who’s Who Legal (2018, 2019). It is also the most successful law firm, providing the most comprehensive legal services in the Czech Republic and Slovakia, based on the total number of all nominations and awards in all years of the Law Firm of the Year awards. The firm became the absolute winner of this competition four times in the last six years, receiving the main award Domestic Law Firm of the Year in the Czech Republic (2015, 2017, 2018, 2020) and ranking as one of the most recommended law firms in all categories of law. Our company is also a three-time winner of the Law Firm of the Year award for Best Client Services (2015, 2016, 2019). In the field of M&A, HAVEL & PARTNERS is the best law firm in the Czech Republic based on the annual International Advisory Experts awards (2018, 2019). In Slovakia, it also won the prestigious global M&A Today Awards (2013–2018) for Mergers & Acquisitions six times in a row, and repeatedly won first place in the ranking by Lawyer International Legal 100 (2017, 2018). Prestigious international rating agencies EMIS DealWatch and Mergermarket have ranked HAVEL & PARTNERS among the leading law firms by the number of transactions completed in the entire CEE region since 2009. Based on annual awards of the Acquisition International magazine, HAVEL & PARTNERS has become the Law Firm of the Year 2019 in the M&A category in the CEE region.

Firm's website: https://www.havelpartners.cz/en/

Our Latest Issue